Tag : GOUT

MSUS has emerged as an invaluable diagnostic and prognostic tool in rheumatology, often complementing clinical evidence to bolster its role in managing patients with rheumatoid arthritis or juvenile idiopathic arthritis. During the 28th Hong Kong Medical Forum, Dr. Ho, Tze-Kwan Carmen shared her insights on the implementation of MSUS and the interpretation of its results in gout management.

Gout represents a prevalent non-communicable disease in Hong Kong's population. As evidenced by a local study, the prevalence of gout witnessed a nearly two-fold increase from 1.56% in 2006 to 2.92% in 2016. This surge has been ascribed to the emergence of multiple risk factors, including an aging